Subsequently, TTYH1 and TTYH2 were reported to serve as VSOR, in a manner independent of LRRC8A, in human cancer cells including gastric SNU-601, hepatic HepG2 and colonic LoVo cells by Bae et al. (2019). Here, LRRC8A is linked to cancer.